Solid pharmaceutical dosage form

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8309613
APP PUB NO 20110015216A1
SERIAL NO

12880781

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A solid pharmaceutical dosage form providing improved oral bioavailability is disclosed for inhibitors of HIV protease. In particular, the dosage form comprises a solid dispersion of at least one HIV protease inhibitor and at least one pharmaceutically acceptable water-soluble polymer and at least one pharmaceutically acceptable surfactant, said pharmaceutically acceptable water-soluble polymer having a Tg of at least about 50° C. Preferably, the pharmaceutically acceptable surfactant has an HLB value of from about 4 to about 10.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ABBVIE INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alani, Laman Foster City, US 42 230
Berndl, Gunther Herxheim, DE 41 433
Breitenbach, Joerg Mannheim, DE 29 448
Ghosh, Soumojeet Lansdale, US 34 301
Liepold, Bernd Dossenheim, DE 39 377
Reinhold, Ulrich Heidelberg, DE 26 233
Rosenberg, Joerg Ellerstadt, DE 60 1496

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 13, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00